Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antipsychotic Agents | 3 | 2007 | 247 | 0.690 |
Why?
|
| Receptors, Nicotinic | 2 | 2006 | 41 | 0.520 |
Why?
|
| Multiple Sclerosis | 1 | 2014 | 132 | 0.440 |
Why?
|
| Referral and Consultation | 1 | 2014 | 383 | 0.410 |
Why?
|
| Depressive Disorder | 1 | 2014 | 621 | 0.370 |
Why?
|
| Memory | 2 | 2007 | 214 | 0.310 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2007 | 20 | 0.290 |
Why?
|
| Parasympathetic Nervous System | 1 | 2007 | 14 | 0.290 |
Why?
|
| Haloperidol | 1 | 2007 | 95 | 0.280 |
Why?
|
| Risperidone | 1 | 2007 | 48 | 0.280 |
Why?
|
| Receptors, Muscarinic | 1 | 2006 | 44 | 0.270 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 213 | 0.260 |
Why?
|
| Dentifrices | 1 | 2005 | 2 | 0.250 |
Why?
|
| Cariostatic Agents | 1 | 2005 | 4 | 0.250 |
Why?
|
| Dental Plaque | 1 | 2005 | 14 | 0.250 |
Why?
|
| Fluorides | 1 | 2005 | 15 | 0.250 |
Why?
|
| Brain Chemistry | 1 | 2005 | 173 | 0.250 |
Why?
|
| Kidney Failure, Chronic | 2 | 2017 | 365 | 0.220 |
Why?
|
| Neurons | 1 | 2007 | 881 | 0.190 |
Why?
|
| Rats, Wistar | 3 | 2007 | 371 | 0.190 |
Why?
|
| Calcium | 1 | 2005 | 929 | 0.190 |
Why?
|
| Osteoporotic Fractures | 1 | 2017 | 9 | 0.150 |
Why?
|
| Brain | 2 | 2006 | 2176 | 0.140 |
Why?
|
| Rats | 4 | 2007 | 5300 | 0.120 |
Why?
|
| Prosthesis-Related Infections | 1 | 2015 | 70 | 0.120 |
Why?
|
| Pacemaker, Artificial | 1 | 2015 | 157 | 0.120 |
Why?
|
| Sex Distribution | 1 | 2014 | 274 | 0.120 |
Why?
|
| Registries | 1 | 2017 | 733 | 0.110 |
Why?
|
| Male | 11 | 2017 | 37321 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 221 | 0.100 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2015 | 296 | 0.100 |
Why?
|
| Defibrillators, Implantable | 1 | 2015 | 329 | 0.100 |
Why?
|
| Fibrinolytic Agents | 1 | 2015 | 377 | 0.100 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2017 | 756 | 0.090 |
Why?
|
| Vesicular Acetylcholine Transport Proteins | 2 | 2007 | 5 | 0.090 |
Why?
|
| Maze Learning | 2 | 2007 | 138 | 0.090 |
Why?
|
| Primary Health Care | 1 | 2014 | 703 | 0.080 |
Why?
|
| Autoradiography | 2 | 2005 | 94 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 507 | 0.080 |
Why?
|
| Cross-Over Studies | 2 | 2006 | 260 | 0.080 |
Why?
|
| Receptor, trkA | 1 | 2007 | 13 | 0.070 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2007 | 19 | 0.070 |
Why?
|
| Time Factors | 2 | 2005 | 4655 | 0.070 |
Why?
|
| Membrane Transport Proteins | 1 | 2007 | 81 | 0.070 |
Why?
|
| Hand Strength | 1 | 2007 | 47 | 0.070 |
Why?
|
| Motor Activity | 2 | 2007 | 621 | 0.070 |
Why?
|
| Telemedicine | 1 | 2015 | 700 | 0.070 |
Why?
|
| Tennis | 1 | 2006 | 2 | 0.070 |
Why?
|
| Rehydration Solutions | 1 | 2006 | 5 | 0.070 |
Why?
|
| Postural Balance | 1 | 2007 | 93 | 0.070 |
Why?
|
| Dehydration | 1 | 2006 | 15 | 0.070 |
Why?
|
| Quality of Life | 1 | 2014 | 1515 | 0.070 |
Why?
|
| Drinking | 1 | 2006 | 35 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2015 | 7029 | 0.070 |
Why?
|
| Bungarotoxins | 1 | 2005 | 3 | 0.070 |
Why?
|
| Densitometry | 1 | 2005 | 15 | 0.070 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2005 | 9 | 0.070 |
Why?
|
| Galantamine | 1 | 2005 | 9 | 0.070 |
Why?
|
| Indans | 1 | 2005 | 20 | 0.070 |
Why?
|
| Receptors, Cholinergic | 1 | 2005 | 30 | 0.070 |
Why?
|
| Animals | 4 | 2007 | 20881 | 0.070 |
Why?
|
| Body Temperature | 1 | 2006 | 116 | 0.070 |
Why?
|
| Nerve Growth Factor | 1 | 2005 | 54 | 0.060 |
Why?
|
| Reflex, Startle | 1 | 2005 | 39 | 0.060 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2005 | 58 | 0.060 |
Why?
|
| Secretory Rate | 1 | 2005 | 11 | 0.060 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2005 | 11 | 0.060 |
Why?
|
| Mouthwashes | 1 | 2005 | 9 | 0.060 |
Why?
|
| Fluoridation | 1 | 2005 | 2 | 0.060 |
Why?
|
| Calcium Chloride | 1 | 2005 | 38 | 0.060 |
Why?
|
| Brazil | 1 | 2005 | 48 | 0.060 |
Why?
|
| Piperidines | 1 | 2005 | 123 | 0.060 |
Why?
|
| Acoustic Stimulation | 1 | 2005 | 206 | 0.060 |
Why?
|
| Placebos | 1 | 2005 | 195 | 0.060 |
Why?
|
| Saliva | 1 | 2005 | 142 | 0.060 |
Why?
|
| Hippocampus | 1 | 2007 | 471 | 0.060 |
Why?
|
| Female | 7 | 2017 | 38074 | 0.060 |
Why?
|
| Protein Binding | 1 | 2006 | 1027 | 0.050 |
Why?
|
| Middle Aged | 3 | 2017 | 21147 | 0.050 |
Why?
|
| Adolescent | 4 | 2015 | 8912 | 0.050 |
Why?
|
| Stroke | 1 | 2015 | 2163 | 0.050 |
Why?
|
| Humans | 8 | 2017 | 68618 | 0.050 |
Why?
|
| Cyclic GMP | 1 | 2001 | 99 | 0.050 |
Why?
|
| Sodium | 1 | 2001 | 161 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2005 | 1738 | 0.050 |
Why?
|
| Endothelin-1 | 1 | 2001 | 122 | 0.040 |
Why?
|
| Aging | 1 | 2005 | 911 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2001 | 382 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2017 | 7277 | 0.040 |
Why?
|
| Sickle Cell Trait | 1 | 1999 | 24 | 0.040 |
Why?
|
| Georgia | 2 | 2015 | 161 | 0.040 |
Why?
|
| Remote Consultation | 1 | 1999 | 50 | 0.040 |
Why?
|
| United States | 3 | 2017 | 7367 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 1999 | 378 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2015 | 89 | 0.030 |
Why?
|
| Device Removal | 1 | 2015 | 100 | 0.030 |
Why?
|
| Child | 1 | 2005 | 6405 | 0.030 |
Why?
|
| Incidence | 1 | 2017 | 1603 | 0.030 |
Why?
|
| Hospitals | 1 | 2015 | 265 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 622 | 0.030 |
Why?
|
| Adult | 4 | 2017 | 21403 | 0.030 |
Why?
|
| Prevalence | 1 | 2015 | 1619 | 0.020 |
Why?
|
| Aged | 2 | 2017 | 14862 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 1851 | 0.020 |
Why?
|
| Thirst | 1 | 2006 | 4 | 0.020 |
Why?
|
| Electrolytes | 1 | 2006 | 47 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 1 | 2006 | 43 | 0.020 |
Why?
|
| Dietary Carbohydrates | 1 | 2006 | 27 | 0.020 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2005 | 30 | 0.020 |
Why?
|
| Acetylcholinesterase | 1 | 2005 | 19 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2005 | 104 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2005 | 87 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 5731 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 5717 | 0.010 |
Why?
|
| Natriuresis | 1 | 2001 | 13 | 0.010 |
Why?
|
| Regional Medical Programs | 1 | 1999 | 22 | 0.010 |
Why?
|
| Confidentiality | 1 | 1999 | 62 | 0.010 |
Why?
|
| Rural Health Services | 1 | 1999 | 101 | 0.010 |
Why?
|
| Hypertension | 1 | 2001 | 1535 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 1999 | 2800 | 0.010 |
Why?
|